Literature DB >> 10383589

The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT).

R Valenta1, J Lidholm, V Niederberger, B Hayek, D Kraft, H Grönlund.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10383589     DOI： 10.1046/j.1365-2222.1999.00653.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  83 in total

Review 1.  Biology of tree pollen allergens.

Authors:  Nadine Mothes; Rudolf Valenta
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 2.  [Microarray technique for component resolved diagnosis (CRD) in type-I allergies. An innovative technology at the border between research tool and routine diagnostics].

Authors:  L Klimek; D Vetter; L von Bernus; C Thorn
Journal:  HNO       Date:  2011-10       Impact factor: 1.284

Review 3.  [Molecular component-resolved allergy diagnostics in ENT].

Authors:  L Klimek; S Becker
Journal:  HNO       Date:  2017-10       Impact factor: 1.284

Review 4.  Natural Evolution of IgE Responses to Mite Allergens and Relationship to Progression of Allergic Disease: a Review.

Authors:  Daniela Posa; Stephanie Hofmaier; Stefania Arasi; Paolo Maria Matricardi
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

Review 5.  Component resolved testing for allergic sensitization.

Authors:  Kirsten Skamstrup Hansen; Lars K Poulsen
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

Review 6.  Recombinant allergens: the present and the future.

Authors:  Marek Jutel; Katarzyna Solarewicz-Madejek; Sylwia Smolinska
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

7.  Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice.

Authors:  K Hufnagl; B Wagner; B Winkler; K Baier; R Hochreiter; J Thalhamer; D Kraft; O Scheiner; H Breiteneder; U Wiedermann
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

8.  [From the allergen-recognition by antibodies to new therapeutic concepts].

Authors:  Brigitte Hantusch; Erika Jensen-Jarolim
Journal:  Wien Med Wochenschr       Date:  2008

9.  Panallergens and their impact on the allergic patient.

Authors:  Michael Hauser; Anargyros Roulias; Fátima Ferreira; Matthias Egger
Journal:  Allergy Asthma Clin Immunol       Date:  2010-01-18       Impact factor: 3.406

10.  Vaccination with genetically engineered allergens prevents progression of allergic disease.

Authors:  V Niederberger; F Horak; S Vrtala; S Spitzauer; M-T Krauth; P Valent; J Reisinger; M Pelzmann; B Hayek; M Kronqvist; G Gafvelin; H Grönlund; A Purohit; R Suck; H Fiebig; O Cromwell; G Pauli; M van Hage-Hamsten; R Valenta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.